Additionally, the promoter of telomerase reverse transcriptase (TERT) gene frequently mutated in bladder carcinoma in which ETS1 bond to the altered promoter and promoted bladder carcinoma migration and progression [41]. This evidence concerns the gene ETS1 and urinary bladder carcinoma.